triple negative breast cancerTNBC#2TNBCTNBC#1pembrolizumabDOD W81XWH-21-2-0034Burroughs Wellcome Physician-Scientist AwardBCRF 24-053
…response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer. Cancer Cell. 2024;42:70–84.Lee KM, et al. Epigenetic repressio…